上集講述了PD1/PDL1在醫治癌細胞免疫治療方面的重要性,接下來我們將會繼續深入探討問題。1232Please respect copyright.PENANAGqoyZCjGIT
1232Please respect copyright.PENANAmpkQyIDHpc
上集:https://www.penana.com/article/4711251232Please respect copyright.PENANA3GLVzMdamU
1232Please respect copyright.PENANA01uxTgQKUH
1232Please respect copyright.PENANA8W9gKXfkb3
1232Please respect copyright.PENANAglTk01udrg
(圖1)雖然阻擋PD1/PDL1可以增強T cell辨認癌細胞的能力,但另一個重要的問題是,如何確保有足夠的T cell殺滅癌細胞呢?1232Please respect copyright.PENANAriJlnqNujo
1232Please respect copyright.PENANAkCLUe4OUJU
就算成功糾正免疫系統細胞懂得把癌細胞辨認為外來之物,但免疫系統細胞數量不足的話,依然是不會達到重大效果的。1232Please respect copyright.PENANABPjMVHiFFN
1232Please respect copyright.PENANA5ki3aQc1Mv
換句話說,我們需要一道能夠提升針對癌細胞的T cell數量手段。1232Please respect copyright.PENANAI2cNJYRTrr
1232Please respect copyright.PENANAOF0KIMxe4Q
1232Please respect copyright.PENANAk2Mo45b6pn
1232Please respect copyright.PENANAtIC2j8MRWx
(圖2)T cell的產生數量,接近可以說是由Antigen Presenting Cells(APC)來決定;1232Please respect copyright.PENANAwSJQAsmd76
APC可以睇成為一堆負責把癌細胞獨特Neoantigen帶來T cell面前的細胞。1232Please respect copyright.PENANAyhQnAfwaki
1232Please respect copyright.PENANAJHaXLsJeUU
忘記甚麼是Neoantigen的話,可重溫上一集。1232Please respect copyright.PENANAcyncEHZxzF
1232Please respect copyright.PENANAYV8cmZaXRp
當APC展示癌細胞的Neoantigen予T cell的receptor後,另一個必需的動作就是T cell表面的CD28與APC表面的B7合併。1232Please respect copyright.PENANANeBGg5piwU
1232Please respect copyright.PENANAD88mPmhVRb
只要兩者條件達成的話,負責對付對應癌細胞的T cell數量及效力便會大增。1232Please respect copyright.PENANAXF8ZZ19XGY
1232Please respect copyright.PENANAbOLbT7JF7k
1232Please respect copyright.PENANAJ7fBrfmD7l
1232Please respect copyright.PENANAxbU3JQOHGq
(圖3)然而,當T cell數量產生至一定程度的時候,T cell便會產生出CTLA4。CTLA4會搶奪CD28的位置,與B7合併。1232Please respect copyright.PENANAqIH4QeO3kZ
1232Please respect copyright.PENANAtVH3att8Zm
而當CTLA4與B7合併後,T cell所產生的數量及威力就會大減。1232Please respect copyright.PENANAirHVjw64rC
1232Please respect copyright.PENANA00swtEKPCe
這個CTLA4產生的機制是與生俱來的,目的就是為了避免產生過量的T cell,以免身體會產生不良反應。1232Please respect copyright.PENANA649p9TMaSY
1232Please respect copyright.PENANAPwTOMkTfRW
1232Please respect copyright.PENANATi9VsTR8Ig
(圖4)只不過的是,現時癌細胞大敵當前,燃眉之急就是要調動大量的T cell前往討伐癌細胞。1232Please respect copyright.PENANAVmSXITr9dO
1232Please respect copyright.PENANAX9kTKSjTOZ
為此,我們重施應對PD1/PDL1故技,利用抗體阻擋CTLA4,確保CD28及B7持續合併,不斷產生效力高強的T cell。1232Please respect copyright.PENANAq6JHrtI81W
1232Please respect copyright.PENANATeTcWeb79m
1232Please respect copyright.PENANAdPfetkfNNz
(圖5)簡略的總結來說,為了確保有足夠的T cell消滅癌細胞,我們不惜採用阻擋CTLA4的抗體,號令身體持續產生效力高強的T cell。1232Please respect copyright.PENANAkDYvpYAQ0O
而另一邊廂,我們亦同時利用阻擋PD1/PDL1的抗體,確保T cell能夠順利把癌細胞辨認成為外來物,將其制裁。1232Please respect copyright.PENANAbs3KGlBagV
1232Please respect copyright.PENANAGXQIL0PJ00
這CTLA4抗體及PD1/PDL1抗體的雙管齊下療法,將能大大提升免疫治療的效率。1232Please respect copyright.PENANAaJWFHJiIEf
1232Please respect copyright.PENANANOLyirVrgs
但是,並不是所有病人也能依靠這方法而得益,原因是T cell沒法能夠順利抵達癌細胞的位置以及滲入癌細胞的內部作有效的消滅。1232Please respect copyright.PENANAEFbWy99hCc
1232Please respect copyright.PENANA9ajoiflJLl
這一方面,我們將會在下一篇免疫治療的最終章再作探討。1232Please respect copyright.PENANALAV5RwGAFE
1232Please respect copyright.PENANA8GL366FYZj
1232Please respect copyright.PENANABYY8pXAEMu
如果想我快啲出文的話,請入去Penana網站科普專欄–薯不揀單俾一個like以及Bookmark,這對我非常之重要。1232Please respect copyright.PENANAxnTAhI8LSR
1232Please respect copyright.PENANADx6cYOfTd4
Link: https://www.penana.com/story/66244/%E7%A7%91%E6%99%AE%E5%B0%88%E6%AC%84-%E8%96%AF%E4%B8%8D%E6%8F%80%E5%96%AE/toc1232Please respect copyright.PENANAoZtY5C5qrG
1232Please respect copyright.PENANAFXWVsyAhoV
同時亦可以在Penana網站裡按「買一嚿/半嚿薯仔」,以課金的方式推動我繼續搜羅資料寫文,多謝。1232Please respect copyright.PENANANN8MO05g90
1232Please respect copyright.PENANAnQ3898OUy3
Link:1232Please respect copyright.PENANA3Ga0vFcXYK
https://www.penana.com/user/27349/%E8%96%AF%E4%BB%94%E8%81%9E%E8%8C%B1%E8%8E%89/portfolio1232Please respect copyright.PENANA6kgK9ZTbyf
1232Please respect copyright.PENANAnhSzgdPd9O
1232Please respect copyright.PENANAJIWnTwwFES
有興趣接收科普資訊的話,歡迎follow IG: potatopigtongue。1232Please respect copyright.PENANAaQmKo758Lj